Miltenyi Bioindustry is a global CDMO service provider specializing in cell and gene therapy. With more than 25 years of experience, we offer comprehensive process development and manufacturing services ...
Proprietary Platform Moves Promising Cell Therapy Candidates from Contract to Clinic in Six Months NEWARK, NJ, June 1, 2023 – BioCentriq®, a strategic CDMO (contract development and manufacturing ...
Monday, January 9, 2023 (Toronto, ON) – Viral vectors are critical components in the manufacturing of cell and gene therapies, but their production is currently a key bottleneck and cost driver. CCRM, ...
Recently, Eutilex, a partner of GenScript ProBio, announced MFDS clearance of its hepatocellular carcinoma clinical trial application for innovative CAR-T program (EU307). GenScript ProBio extends congratulations ...
Sponsored Article Provided by Thermo Fisher Thermo Fisher Scientific Patheon Translational Services facility in San Diego The advanced therapies field is expected to grow at an ...
OmniaBio Expands Manufacturing Footprint with Second Hamilton Location January 24, 2023 (Hamilton, ON) – OmniaBio Inc. has expanded its footprint by adding a new process and analytical development ...
MicrofluidX and CCRM Partner on End-to-End Bioprocessing of CAR-T Cell Therapies Stevenage, UK, and Toronto, Canada, January 11, 2023— MicrofluidX (MFX), a UK-based provider of next-generation bioreactors ...
BioCentriq, Inc.—a New Jersey-based, cell and gene therapy contract development and manufacturing organization (CDMO)—announced today that they've completed a study designed to test transfection of T-cells ...
Sponsored article provided by Santen Founded in Japan over a century ago, Santen has been contributing to people’s eye health for the past 130 years. During this time the company has expanded to ...
Members in the News: Minaris Regenerative Medicine Minaris Regenerative Medicine GmbH and Mendus AB extend manufacturing partnership to large-scale production of DCP-001, an experimental allogeneic ...
Sponsored article provided by CCRM Architect’s rendering of OmniaBio facility under construction in Hamilton, Ontario Globally, the race is on to bring facilities online that ...
Meet the Investor Brought to you by the ISCT Business Development & Finance Committee Bryan Poltilove Operating Partner BroadOak Capital Partners As Operating ...
ISCT Asia Pacific (APAC) Industry Committee Furthering ISCT’s role in facilitating global and regional strategic partnerships, in March 2022, ISCT Industry Leadership launched the Asia Pacific ...
Members in the News: Ori Biotech and CTMC partner to accelerate novel cell therapy delivery London, UK, and Houston, TX, US, September 13, 2022 – Ori Biotech (Ori), a leader in cell and gene ...
Industry Members in the News Funding from Ontario government launches OmniaBio Inc. OmniaBio Inc’s new facility will be the largest CDMO in Canada for the manufacture of CGTs ...
Meet the Investor Segment Brought to you by the ISCT Business Development & Finance Committee Jonathan Yeh, PhD Partner & Co-Founder Saisei Ventures Canada ...
Publication from ISCT Process Development and Manufacturing Committee Impact considerations of post-production processes on cell and gene drug products PUBLISHED IN CYTOTHERAPY - VOLUME 24, ISSUE ...
First 3 Webinars from the Cryopreservation Webinar Series Available Online Brought to you by the ISCT Process & Product Development Committee Part 1: An Appreciation of Cryopreservation and ...